Infectious Diseases News and Research

RSS

Bed nets and insecticides could fail to protect people from new malaria-transmitting mosquitoes

A potentially dangerous new malaria-transmitting mosquito has been discovered in Kenya by scientists from the London School of Hygiene & Tropical Medicine. This species, which has never been implicated in the transmission of malaria before, poses a threat because it bites humans at times when they are not protected by current malaria control techniques.

17 Sep 2012

SLU study: Many U.S. schools not prepared for bioterrorism attacks, outbreaks of pandemics

Many U.S. schools are not prepared for bioterrorism attacks, outbreaks of emerging infectious diseases or pandemics, despite the recent 2009 H1N1 influenza pandemic that resulted in more than 18,000 deaths worldwide, Saint Louis University researchers say.

15 Sep 2012

Popular Science magazine names UCLA professor among ‘Brilliant 10’

Popular Science magazine has named Aydogan Ozcan, an associate professor of electrical engineering and bioengineering at UCLA, one of the world's "Brilliant 10" scientists in its October 2012 issue.

15 Sep 2012

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP.

15 Sep 2012

Radiographs ‘unnecessary’ after splinting

US researchers question the need for an X-ray after splinting, finding that most fracture patients do not benefit from this service.

14 Sep 2012

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.

14 Sep 2012

Loss of normal microbial diversity may be culprit behind chronic sinusitis

A common bacteria ever-present on the human skin and previously considered harmless, may, in fact, be the culprit behind chronic sinusitis, a painful, recurring swelling of the sinuses that strikes more than one in ten Americans each year, according to a study by scientists at the University of California, San Francisco.

13 Sep 2012

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing novel antibiotics effective against antibiotic-resistant bacteria, presented new, positive Phase 2 clinical data on its lead drug candidate, eravacycline (TP-434), on September 11, 2012, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

13 Sep 2012

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Pfizer Inc., the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, today announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd., a joint venture formed between the two companies to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

13 Sep 2012

PrimeraDx’s ICEPlex system and C. difficile detection assay receive CE mark

PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex system, a quantitative multiplex PCR system, and their C. difficile detection assay both received the CE mark.

12 Sep 2012

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years.

12 Sep 2012

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."

12 Sep 2012

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

e-Therapeutics plc announces that it has started a second phase I clinical trial of its anti-cancer drug ETS2101. This trial will enrol up to 45 patients with a variety of solid tumours at two UK centres, St James's University Hospital in Leeds and the Northern Centre for Cancer Care at the Freeman Hospital in Newcastle.

12 Sep 2012

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

A Devex news analysis examines the Democratic and Republican platform positions on foreign policy following the party conventions, writing, "Even as pocketbook concerns continue to overshadow foreign policy issues on the campaign trail, in both Charlotte and Tampa, top-billed speakers made the case for the U.S. foreign aid program."

12 Sep 2012

Try resuscitating a little longer, say researchers

Researchers report in The Lancet that the duration of resuscitation attempts varies widely between hospitals and increasing it could improve survival in patients with cardiac arrest.

11 Sep 2012

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

Durata Therapeutics today announced results from its QT study of the company's lead product candidate, dalbavancin. Dalbavancin is currently under investigation in two ongoing, global, Phase 3 clinical trials for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

11 Sep 2012

BRI scientists receive two major grant awards for research into autoimmunity prevention

Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases.

11 Sep 2012

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Although people often say they have "strep" throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldn't be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.

11 Sep 2012

Infectious Diseases News and Research

Bed nets and insecticides could fail to protect people from new malaria-transmitting mosquitoes

SLU study: Many U.S. schools not prepared for bioterrorism attacks, outbreaks of pandemics

Popular Science magazine names UCLA professor among ‘Brilliant 10’

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Radiographs ‘unnecessary’ after splinting

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

Loss of normal microbial diversity may be culprit behind chronic sinusitis

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

PrimeraDx’s ICEPlex system and C. difficile detection assay receive CE mark

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

Try resuscitating a little longer, say researchers

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

BRI scientists receive two major grant awards for research into autoimmunity prevention

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

First demonstration of newly developed dual humanized FRGTM KO system against malaria

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News